|

Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures

RECRUITINGN/ASponsored by Asian Institute of Gastroenterology, India
Actively Recruiting
PhaseN/A
SponsorAsian Institute of Gastroenterology, India
Started2026-02-16
Est. completion2026-04-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07399652

Summary

This prospective study aims to evaluate the performance of a novel Artificial Intelligence (AI) clinical decision support tool during third space endoscopic procedures, such as Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). While these procedures are effective for treating gastrointestinal neoplasms and motility disorders, they carry risks of intraprocedural bleeding and perforation if submucosal blood vessels are not correctly identified and coagulated. Building on previous retrospective validation, this study will assess whether a real-time artificial intelligence model can assist endoscopists in detecting and delineating blood vessels more accurately and faster during live human procedures.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients diagnosed with Achalasia Cardia or neoplasms.

Exclusion Criteria:

* Patients with conditions deemed unsuitable for third space endoscopy procedures (e.g.: Candidiasis)

Conditions3

Achalasia CardiaCancerTumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.